Assura Plc (LON:AGR – Get Free Report) insider Jonathan Murphy acquired 198,975 shares of the firm’s stock in a transaction dated Tuesday, May 21st. The shares were acquired at an average price of GBX 43 ($0.55) per share, with a total value of £85,559.25 ($108,743.33).
Jonathan Murphy also recently made the following trade(s):
- On Tuesday, May 7th, Jonathan Murphy bought 774 shares of Assura stock. The shares were acquired at an average cost of GBX 42 ($0.53) per share, for a total transaction of £325.08 ($413.17).
- On Friday, April 5th, Jonathan Murphy purchased 786 shares of Assura stock. The stock was acquired at an average cost of GBX 41 ($0.52) per share, with a total value of £322.26 ($409.58).
- On Tuesday, March 5th, Jonathan Murphy acquired 351 shares of Assura stock. The stock was bought at an average cost of GBX 43 ($0.55) per share, with a total value of £150.93 ($191.83).
Assura Trading Down 1.4 %
Shares of Assura stock opened at GBX 40.18 ($0.51) on Friday. The firm has a fifty day moving average price of GBX 41.67 and a 200 day moving average price of GBX 43.54. Assura Plc has a 1 year low of GBX 38.38 ($0.49) and a 1 year high of GBX 50.75 ($0.65). The company has a debt-to-equity ratio of 82.21, a current ratio of 1.29 and a quick ratio of 2.84. The stock has a market cap of £1.20 billion, a PE ratio of -669.67, a price-to-earnings-growth ratio of 3.60 and a beta of 0.30.
Assura Increases Dividend
Analyst Upgrades and Downgrades
A number of research analysts have issued reports on the stock. Shore Capital restated a “buy” rating on shares of Assura in a research note on Tuesday. Peel Hunt lowered Assura to an “add” rating and set a GBX 48 ($0.61) target price for the company. in a research note on Wednesday, March 20th. Finally, Barclays reiterated an “overweight” rating and set a GBX 53 ($0.67) price target on shares of Assura in a research note on Friday, February 9th. One analyst has rated the stock with a hold rating and four have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of GBX 52 ($0.66).
Get Our Latest Stock Report on AGR
About Assura
Assura plc is a national healthcare premises specialist and UK REIT based in Altrincham, UK – caring for more than 600 primary healthcare buildings, from which over six million patients are served. A constituent of the FTSE 250 and the EPRA indices, as at 30 September 2023, Assura's portfolio was valued at £2.7 billion.
Featured Articles
- Five stocks we like better than Assura
- When to Sell a Stock for Profit or Loss
- What is a Short Call Butterfly Spread? Explanation with Examples
- 3 Home Improvement Stocks that Can Upgrade Your Portfolio
- First Quarter Wrap-Up Reveals Retail’s Shifting Sands
- Buy P&G Now, Before It Sets A New All-Time High
- Williams-Sonoma Stock Forecast to Hit $500? Here’s How
Receive News & Ratings for Assura Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Assura and related companies with MarketBeat.com's FREE daily email newsletter.